Log in to save to my catalogue

Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with Tha...

Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with Tha...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A702555046

Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy

About this item

Full title

Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Oncology, 2021-04, Vol.99 (5), p.327-335

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Introduction: The clinical outcome of ramucirumab in multi-molecular targeted agent (MTA) sequential therapy for unresectable hepatocellular carcinoma (u-HCC) was assessed in comparison with that of prior tyrosine kinase inhibitor (TKI) therapy. Methods: Sixteen patients who received ramucirumab as part of multi-MTA sequential therapy for u-HCC wer...

Alternative Titles

Full title

Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A702555046

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A702555046

Other Identifiers

ISSN

0030-2414

E-ISSN

1423-0232

DOI

10.1159/000514315

How to access this item